
Ablynx has appointed Dr Robert Zeldin as chief medical officer (CMO) effective from 1 December 2015. Dr Zeldin will lead …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
Alcami appoints Will Isom to lead laboratory services sales

